Latest updates for Oprx

Fresh curated links around OPRX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • OptimizeRx (OPRX) Q1 2026 Earnings Transcript
  • Option Care (OPCH) Climbs 5.9% on US Healthcare Developments
  • Obsidian, Galera to advance cell therapy following reverse merger

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fool.com /2 weeks ago

OptimizeRx (OPRX) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DATETuesday, May 12, 2026, at 4:30 p.m. ETCALL PARTICIPANTSChief Executive Officer — Stephen L. SilvestroChief Financial Officer — Edward StelmakhCh...

Read source
finance.yahoo.com /1 week ago

Option Care (OPCH) Climbs 5.9% on US Healthcare Developments

Read source
biopharmadive.com /1 month ago

Obsidian, Galera to advance cell therapy following reverse merger

The combined company will trade on the Nasdaq under the ticker OBX. It has also secured commitments for a private placement expected to deliver $350 million in gross proceeds.

Read source
finance.yahoo.com /2 weeks ago

Leerink Partners Lifts PT on Oruka Therapeutics, Inc. (ORKA)

Read source
seekingalpha.com /1 month ago

ORIC Pharmaceuticals, Inc. (ORIC) Discusses Rinzimetostat Dose Optimization Data and Phase III Trial Design in Metastati...

Read source
seekingalpha.com /3 weeks ago

Option Care Health, Inc. 2026 Q1 - Results - Earnings Call Presentation

Read source
seekingalpha.com /1 week ago

NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript

Read source
seekingalpha.com /1 month ago

Protalix: Elfabrio Struggles Against Oral Competition

Read source
seekingalpha.com /3 weeks ago

Oppenheimer Holdings Inc. (OPY) Shareholder/Analyst Call Transcript

Read source
seekingalpha.com /4 weeks ago

Pacira BioSciences, Inc. 2026 Q1 - Results - Earnings Call Presentation

Read source
seekingalpha.com /1 month ago

Omeros Corporation (OMER) Q4 2025 Earnings Call Transcript

Read source
pharmexec.com /2 weeks ago

<![CDATA[John Oyler: Rewiring Operations in Oncology]]>

Read source
fool.com /10 hours ago

RXO Stock Has Surged 75% Since This Fund Made a $10 Million Bet

RXO uses a digital freight marketplace to deliver asset-light logistics and transportation solutions across multiple U.S. industries.

Read source
seekingalpha.com /2 weeks ago

Ars Pharmaceuticals anticipates CVS Caremark decision as it expands $199 retail access program

Read source
pharmexec.com /2 days ago

<![CDATA[CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo]]>

Read source
fiercehealthcare.com /4 weeks ago

Omada signs on with Optum Rx's GLP-1 management program

Omada Health has signed on with Optum Rx to participate in its Weight Engage program, furthering the company's ability to scale its offerings to reach more people who need cardiome...

Read source
finance.yahoo.com /1 month ago

Wolfe Research Initiates Coverage of BeOne Medicines AG (ONC) with Outperform Rating

Read source
seekingalpha.com /4 days ago

Onward Medical N.V. (ONWRY) Q1 2026 Earnings Call Transcript

Read source
genengnews.com /1 month ago

StockWatch: Price War Dampens Lilly Surge After Oral GLP-1 Wins FDA Nod

Trung Huynh, an analyst with RBC Capital Markets, has projected Foundayo will reach peak-year sales of $36 billion—14% above the $31.68 billion racked up by last year’s best sellin...

Read source
seekingalpha.com /2 weeks ago

Royalty Pharma: Strong Execution, Expanding Pipeline And More Firepower Ahead

Read source
fool.com /2 weeks ago

A Director Keeps Buying OPCH as It Falls — and the Timing Is His Own

Shares of this national infusion therapy provider have drawn fresh insider buying following a year of notable price declines.

Read source
seekingalpha.com /1 month ago

Organon: What The Buyout Rumors Mean For The Stock

Read source
qchron.com /4 weeks ago

Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalen...

TORONTO, May 1, 2026 /PRNewswire/ - Apotex Inc. ("Apotex" or the "Company"), Canada's largest Canadian‑based global health company, today announced that Health Canada has approved...

Read source
seekingalpha.com /1 month ago

OP Bancorp GAAP EPS of $0.48 beats by $0.07, revenue of $24.56M beats by $0.16M

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Oprx

seekingalpha.com

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

finance.yahoo.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

biopharmadive.com

Recent coverage from public sources
Public source